Assyro AI

Orange Book product · Generic (ANDA)

BRETYLIUM TOSYLATE

BRETYLIUM TOSYLATE

Generic (ANDA)ANDA 071298DISCN ABRAXIS PHARM

At a glance

Feb 13, 1987

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Feb 13, 1987

    39 yr 11 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

BRETYLIUM TOSYLATE

Strength

100MG/ML

Dosage form

INJECTABLE

Route

INJECTION

TE code

Not listed

Application

ANDA 071298

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of BRETYLIUM TOSYLATE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.